[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.47.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 4, 1974

Evaluation of an Antiasthmatic Agent Cromolyn Sodium (Aarane, Intal)

Author Affiliations

Dr. Dykes is Senior Scientist, AMA Department of Drugs. This communication was prepared with the assistance of consultants.

JAMA. 1974;227(9):1061-1062. doi:10.1001/jama.1974.03230220051020
Abstract

Cromolyn sodium is a unique and effective antiasthmatic agent that has been used widely throughout the world. Its continuous prophylactic use will benefit a large proportion of asthmatic patients. In many it will be most effective when administered with other standard drugs. Cromolyn has no place in the treatment of acute asthmatic attacks. When inhaled orally in therapeutic doses, it appears to have no generalized pharmacologic activity and causes few significant adverse effects.

×